Stereotactic Ablative Radiotherapy Induces Peripheral T-Cell Activation in Patients with Early-Stage Lung Cancer

Am J Respir Crit Care Med. 2017 Nov 1;196(9):1224-1227. doi: 10.1164/rccm.201610-2178LE.

Authors

Pauline L de Goeje¹, Egbert F Smit², Cynthia Waasdorp¹, Merel T B Schram^{1

3}, Margaretha E H Kaijen-Lambers¹, Koen Bezemer¹, Mark de Mol^{1

3}, Koen J Hartemink², Joost J M E Nuyttens¹, Alexander P W M Maat¹, Joost P J J Hegmans¹, Rudi W Hendriks¹, Suresh Senan⁴, Joachim G J V Aerts^{1

3}

Affiliations

¹ 1 Erasmus MC Rotterdam, the Netherlands.
² 2 Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital Amsterdam, the Netherlands.
³ 3 Amphia Hospital Breda, the Netherlands and.
⁴ 4 VU Medical Center Amsterdam, the Netherlands.

PMID: 28345951
DOI: 10.1164/rccm.201610-2178LE

No abstract available

Publication types

Comparative Study
Letter
Observational Study
Research Support, Non-U.S. Gov't

MeSH terms

Carcinoma, Non-Small-Cell Lung / immunology
Carcinoma, Non-Small-Cell Lung / pathology
Carcinoma, Non-Small-Cell Lung / therapy*
Humans
Linear Models
Lung Neoplasms / immunology
Lung Neoplasms / pathology
Lung Neoplasms / therapy*
Lymphocyte Activation / immunology*
Neoplasm Staging
Radiosurgery*
T-Lymphocytes / immunology*
Thoracic Surgical Procedures*
Treatment Outcome

Associated data

ClinicalTrials.gov/NCT02488850